Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

21.01
-0.3500-1.64%
Post-market: 21.010.00000.00%19:47 EDT
Volume:1.01M
Turnover:21.34M
Market Cap:2.57B
PE:12.75
High:21.30
Open:21.16
Low:20.88
Close:21.36
52wk High:26.58
52wk Low:19.05
Shares:122.39M
Float Shares:115.02M
Volume Ratio:1.02
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.65
EPS(LYR):1.38
ROE:28.49%
ROA:18.13%
PB:3.00
PE(LYR):15.19

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
Catalyst Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
2002
Employees:
181
Office Location:
355 Alhambra Circle,Suite 801,Coral Gables,Florida,United States
Website:
http://www.catalystpharma.com
Zip Code:
33134
Phone:
305 420 3200
Fax:
- -
Introduction:
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Directors

Name
Position
Patrick J. McEnany
Non-Executive Chairman of the Board
Richard J. Daly
Director, President and Chief Executive Officer
David S. Tierney
Independent Director
Donald A. Denkhaus
Independent Director
Molly Harper
Lead Independent Director
Tamar Thompson
Independent Director
Daniel J. Curran
Director

Shareholders

Name
Position
Richard J. Daly
Director, President and Chief Executive Officer
Steven R. Miller
Executive Vice President, Chief Operating Officer and Chief Scientific Officer
Michael W. Kalb
Executive Vice President,Treasurer, Chief Financial Officer and Principal Accounting Officer
Brian Elsbernd
Chief Compliance Officer and Chief Legal Officer
Gary Ingenito
Chief Medical Officer and Chief Regulatory Officer
Gregg Russo
Chief Human Resources Officer
Jeffrey Del Carmen
Executive Vice President and Chief Commercial Officer
Preethi Sundaram
Chief Strategy Officer